Autopsy report · NCT01937572

Visionaire: A Prospective Study

“An interim analysis found the study would not be able to reach significance without a large increase in subjects which was not feasible.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 9 months after it had already started.
• Ran for about 5 years 3 months before it stopped.
• 149 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

The Hawkins Foundation

Sponsor type

University, hospital or other

Conditions

Osteoarthritis

Interventions

Visionaire system (Knee MRI); No Knee MRI

Participants

149

Sites

1

Countries

United States

Trials that died the same way

• It's Native: Nudging Healthy Ways
  “The study was disrupted by the COVID-19 pandemic and there it was not possible to meet study goals within the required timeframe.” (74% match in meaning)
• Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer
  “Interim analysis determined the study did not meet criteria to proceed” (73% match in meaning)
• Impact of an Immune Modulator Dimethyl Fumarate on Acute Ischemic Stroke
  “The interim analysis of another associated study is not very effective” (71% match in meaning)
• Study of Pemetrexed for Second-Line Pancreas Cancer
  “At interim analysis the study did not meet the response criteria to continue” (69% match in meaning)
• Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients Renal Cell Carcinoma
  “The study did not meet endpoint.” (68% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.